EMJ Neurology 9 [Supplement 3] . 2021

In this issue

‘Emerging Treatment Strategies for Motor Fluctuation Management: Therapeutic Options for Newly Detected Motor Fluctuations’ reviews a series of posters on the topic of Parkinson’s disease (PD) presented at the 7th Congress of the European Academy of Neurology (EAN) 2021. Posters presented included real-world data on the efficacy and safety of emerging treatments for patients with PD, with a focus on opicapone (ONGENTYS®, Bial, Trofa, Portugal), a catechol-O-methyltransferase inhibitor developed to manage motor fluctuations, symptoms that severely impact patient quality of life.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.

Thank you!

Please share some more information on the rating you have given